Skip to main
  1. Stocks
  2. Acadia Healthcare
  3. Forecast
ACHC

Acadia Healthcare (ACHC) Stock Forecast & Price Target

Acadia Healthcare (ACHC) Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 42%
Buy 17%
Hold 33%
Sell 8%
Strong Sell 0%

Bulls say

Acadia Healthcare Co is viewed positively because its 3Q26 results showed stronger-than-expected revenue of $895M, EBITDA of $176M, and same-facility revenue growth of 5.2%, supported by 4.0% pricing gains and stable payor dynamics. The bullish case also rests on the company’s improving operational execution, with 2026 EBITDA guidance raised to $615M-$625M, startup losses trending better, and new facilities reaching licensing, accreditation, and contracting milestones faster than expected. Longer term, management expects about $60M of incremental EBITDA in 2027 from the 2023-2026 new-facility cohort, alongside lower capex and potential added benefits from FL and OH programs that could further strengthen cash flow.

Bears say

Acadia Healthcare Co is facing a cautious outlook because management’s limited sizing of 2027 tailwinds and headwinds leaves the implied ~$672M starting point vulnerable to downside from PLGL, NY Medicaid/PA backfill, CTC revenue, investigation costs, and more than $20M of FL and OH DPP under review. The company also faces execution risk as newly added beds from 2023-2026 may ramp slower than expected, while Medicaid funding and reimbursement pressure, regulatory scrutiny, and tighter labor supply could compress margins and reduce cash generation. Even with the ~10% adj. EBITDA growth implied by the 2023-26 cohorts, the negative backdrop suggests those gains may be offset by cost inflation, operating volatility, and limited visibility into future earnings quality.

Acadia Healthcare (ACHC) has been analyzed by 12 analysts, with a consensus rating of Buy. 42% of analysts recommend a Strong Buy, 17% recommend Buy, 33% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Acadia Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Acadia Healthcare (ACHC) Analyst Forecast & Price Prediction

Get the latest Acadia Healthcare (ACHC) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Acadia Healthcare (ACHC)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Acadia Healthcare (ACHC) Forecast

Analysts have given Acadia Healthcare (ACHC) a Buy based on their latest research and market trends.

According to 12 analysts, Acadia Healthcare (ACHC) has a Buy consensus rating as of Nov 13, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $32, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $32, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Acadia Healthcare (ACHC)


Acadia Healthcare (ACHC) Analyst Forecast & Price Prediction

Get the latest Acadia Healthcare (ACHC) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Acadia Healthcare (ACHC)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover ACHC stock data and trends